Effect of HCV infection on hepatic fibrosis in patients of thalassaemia major

Journal of the College of Physicians and Surgeons Pakistan

Volumn 16, Issue 3, 2006, Pages 200-203

  Anwar, Masood ^a   Nadeem, Ali ^a   Jamal, Shahld ^b   Dilawar, Muhammad ^a   Ali, Waqar ^c   Aziz, Shahid ^c   Ayyub, Muhammad ^a   Khalilullah, ^b   Ahmed, Pervez ^b   Ashraf, Tanveer ^c   Khan, Badshah ^b   Hussain, Tasawwar ^d   Hussain, Shujaat ^d  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^b National University of Medical Sciences   (Pakistan)

^c Peshawar Cantonment   (Pakistan)

^d AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Bone marrow transplant modified pessaro criteria; Fibrosis; Hepatitis C; Serum ferritin; Thalassaemia major

Indexed keywords

FERRITIN;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BIOPSY; BLOOD; BONE MARROW TRANSPLANTATION; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS C; HUMAN; IMMUNOASSAY; INFANT; LIVER; LIVER CIRRHOSIS; MALE; PATHOLOGY; PRESCHOOL CHILD; STATISTICAL ANALYSIS;

ADOLESCENT; BETA-THALASSEMIA; BIOPSY; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; FERRITINS; HEPATITIS C; HUMANS; IMMUNOASSAY; INFANT; LIVER; LIVER CIRRHOSIS; MALE;

EID: 39049179101     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Khattak. MF, Saleern M. Prevalence of heterozygous β-thalassaemia in northern Pakistan, J Pak Med Assoc 1992; 42: 32-34
2. Ahmed S, Saleern M, Sultana N, Raashid Y Waqar A. Anwar M. et al. Prenatal diagnosis of β-thalassaemia in Pakistan: experience in Muslim country, Premat Diagn 2000; 20: 373-383 (Pubitemid 30261157)
3. Ahmed S, Petrou M, Saleern M, Molecular genetics of β-thalassaemla in Pakistan: a basis for prenatal diagnosis. Er J Haematol 1996; 94:476-482 (Pubitemid 26284070)
4. Weatherall DJ, Bone marrow transplantation for thalassaemia and other inherited disorders of haemoglobin (editorial). Blood 1992; 80: 1379-1381
5. Suvatte V. Stem cell transplantation in thalassaemias. In: Mc Arthur JR, Lec SH, Jootar S, Unqkano A, Bajus J, (edi). IX Congress of the International Society of Haematology-Asia Pacific Region. Bankok: Intern Soc Haematol 1999; 107-109
6. Lucarelli G, Gift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D, et al. Bone marrow transplantation in adult thlassaemic patients. Blood 1999; 93: 1164-1167 (Pubitemid 29076130)
7. Kershko C, Konijn AM, Link G. Recent advances in iron metabolism, In: Mc Arthur JR, Lee SH, Jootar S, Ungkano A, Bajus J, (edi). IX congress of the International Society of Haematoiogy, Asia Pacific Region. Bankok: intern Soc Haematol 1999:224-228
8. Rodgers GP, Haemoglobinopaties: the thalassemias, In: Goldman L, Benett JC, (edi). Cecil text book of medicine. 21 st ed. Philadelphia: W B Saunder, 2000: 884-889
9. Brittenharn GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS. Tucker EE, et al. Efficacy of desferoxamine in preventing complications of iron overload in patients with thalassaemia major, N, Engl J Med 1994; 331: 567-573
10. Olivieri NF, Nathan DG. MacMillan JH, Wayne AS, Liu PP, McGee A, et al. Survival in medically treated patients with homozygous β-thalassaemia. N Engl J Med 1994; 331: 574-578 (Pubitemid 24265699)
11. Zurlo MG, De Stefano P, Borgna-Pignatti C. Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassaemia major. Lancet 1989; 2: 27-30. (Pubitemid 19158169)
12. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian working group on endocrine complications in non-endocrine disease. Clin Endocrinol 1995 42: 581-586
13. Lucarelli G. Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Mat 1993; 329: 840-844 (Pubitemid 23267211)
14. Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Giardini C, et al. Needle liver biopsy in thalassaemia: analysis of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995; 89: 757-761
15. Finch C. Regulators of iron balance in humans. Blood 1994; 84: 1897-2702
16. Pynard D, Bedossa P, Opolon P. Natural history of liver tirbrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832
17. Kelly D, Skidmore S. Hepatitis CZ: recent advances. Arch Dis Child 2002; 86: 339-343
18. Bhatti FA, Amin M, Saleern M. Prevalence of antibody to hepatitis C virus In Pakistani thalassaemics by particle agglutination test utilizing C-200 and C 22-3 viral antigen coated particle, J Pak Med Assoc 1995; 45: 269-271
19. Telfer PT Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic Iron concentration combined with long term overload in thalassaemia major, Br J Haematol 2000; 110: 971.
20. Ghavamzadeh A. Nasseri P, Shraghian MR, Jahani M, Baybordi I, Nateghi J, et al Prognostic factors in bone marrow transplantation for beta thalassaemia major: experience from Iran. Bone Marror Transplant 1998; 22: 167-169 (Pubitemid 29021125)
21. Angellucci E. Giovognoni A, Valeri G, Paci E, Ripalti M, Muretto P, et al. Limitations of magnetic resonance imaging in measurement of hepatic iron. Blood 1997; 90: 4736-4742 (Pubitemid 28007186)
22. Prati D, Zanella A. Farma E. De Mattel C, Bosoni P. Zappa M, et al. A multicenter prospective study on the risk ol acquiring liver disease in anti hepatitis C virus negative patients affected from homozygous beta thalassaemia. Blood 1998; 92: 3460-3469
23. Risdon RA. Barry M, Flynn DM. Transfusional iron overload. The relationship between tissue iron concentration and hepatic fibrosis in thalassaemia, J Patbol 1975; 116: 83-95.
24. Li CK, Chik KW, Lam CW, To KF, Yu SC, Lee V, et al Liver disease in transfusion dependent thalassaemia major. Arch Dis Child 2002; 86: 344-347 (Pubitemid 34478230)